Search All News
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer’s disease.
A new initiative led by Columbia University and the n-Lorem Foundation will develop personalized therapies for individuals with "nano-rare" genetic forms of ALS and treat them for free, for life.
Discovery reveals that a protein normally involved in clearing cells of molecular debris can clump into fibrils, potentially hobbling cells
- January 20, 2022
Walking is the most natural of movements. Without thinking, we put one foot forward and then the next, on and on, propelling us forward.
- October 25, 2021
Vagelos College of Physicians and Surgeons and College of Dental Medicine scientists awarded $3.97 million to study link between Alzheimer’s and periodontitis
- October 18, 2021
Dr. Manly was elected to NAM for her pioneering work improving detection of cognitive impairment among racially, culturally, and socio-economically diverse adults
- October 5, 2021
Six Columbia University scientists have received NIH High-Risk, High-Reward grants that are given to exceptionally creative scientists proposing unconventional, but potentially high-impact, research
- June 22, 2021
The universal marker of aging is not always a one-way process.
- June 10, 2021
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
Source:CUIMC NewsroomFebruary 8, 2021
Cells used to study the human blood brain barrier in the lab aren’t what they seem, throwing nearly a decade’s worth of research into question